AIM
RDY icon

Acrospire Investment Management’s Dr. Reddy's Laboratories RDY Stock Holding History

Acrospire Investment Management’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-5,500
Closed -$56K – 2125
2016
Q2 		$56K Buy
5,500
+2,500
+83% +$22.9K 0.04% 972
2016
Q1 		$27K Buy
+3,000
New +$26.8K 0.02% 1380

Other funds holding RDY

Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
CBOA
Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VAM
Vontobel Asset Management New York $18.1B AUM 28.09% 1-Year Est. Return
BG
BlackRock Group London, United Kingdom $210B AUM 15.5% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Acrospire Investment Management's RDY Position: Q3 2016 in Review

Acrospire Investment Management sold out of Dr. Reddy's Laboratories (RDY) in Q3 2016, closing a stake of 5,500 shares — an estimated $56K sold.

Acrospire Investment Management first reported a position in RDY in Q1 2016 and held it in 2 quarters. The position peaked at $56K in Q2 2016. 156 funds tracked by Wall St. Rank hold RDY as of Q3 2016.

  • Acrospire Investment Management reported no remaining Dr. Reddy's Laboratories position as of Q3 2016 after selling out during the quarter.
  • Acrospire Investment Management sold 5,500 Dr. Reddy's Laboratories shares in Q3 2016, an estimated $56K.
  • Acrospire Investment Management first reported a position in Dr. Reddy's Laboratories in Q1 2016 and held it in 2 quarters.
  • Acrospire Investment Management's Dr. Reddy's Laboratories position peaked at $56K in Q2 2016.
  • 156 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q3 2016.

Based on Acrospire Investment Management's 13F filing for Q3 2016, filed 10 Nov 2016.